NCT00753740 2020-06-12Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.Lumos PharmaPhase 2 Withdrawn
NCT00333502 2020-05-28Study of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsLumos PharmaPhase 1/2 Completed62 enrolled